Agilent Technologies Inc
A
$146.36 2.09%
Exchange: NYSE | Sector: Healthcare | Industry: Medical Diagnostics Research
Q4 2024
Published: Dec 20, 2024

Earnings Highlights

  • Revenue of $1.70B up 0.8% year-over-year
  • EPS of $1.21 decreased by 25.8% from previous year
  • Gross margin of 53.9%
  • Net income of 351.00M
  • ""...our total company book-to-bill was greater than one. This points to a steady market improvement we are seeing and we expect it to continue in 2025."" - Padraig McDonnell

Agilent Technologies Inc. (A) Q4 2024 Financial Results: Steady Recovery with Strong Market Position and Growth Outlook

Executive Summary

Agilent Technologies Inc. reported Q4 2024 revenues of $1.701 billion, marking a growth of approximately 1% year-over-year. This performance underscores the company’s gradual recovery from previous market challenges, enhanced by a robust demand for its life sciences and diagnostics solutions. Despite facing headwinds in certain segments, Agilent's strong cash flow and efficient cost management strategies have positioned the company favorably as it navigates a dynamic market landscape. CEO Padraig McDonnell expressed confidence in the company's new market-focused organizational structure, which aims to drive customer-centric innovations and operational efficiencies. Management anticipates continued growth in fiscal 2025, bolstered by initiatives such as the Ignite transformation program, which is expected to enhance revenue and margin capture.

Key Performance Indicators

Revenue

1.70B
QoQ: 7.79% | YoY:0.77%

Gross Profit

916.00M
53.85% margin
QoQ: 7.13% | YoY:0.11%

Operating Income

408.00M
QoQ: 22.52% | YoY:0.00%

Net Income

351.00M
QoQ: 24.47% | YoY:-26.11%

EPS

1.21
QoQ: 24.74% | YoY:-25.77%

Revenue Trend

Margin Analysis

Key Insights

1. **Revenue**: Q4 2024 revenue was $1.701 billion, a 0.8% increase from Q3 2024 and flat on a core basis.\n2. **Gross Profit**: Achieved $916 million in gross profit, yielding a gross margin of 54%.\n3. **Operating Income**: Registered $408 million, with an operating margin of 27.4%, slightly lower than previous quarters due to lower volumes and product mix shifts.\n4. **Net Income**: Recorded net income of $351 million, resulting in diluted EPS of $1.21, marking a decline of 25.8% year-over-ye...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 1,668.00 0.75 +6.0% View
Q1 2025 1,681.00 1.11 +1.4% View
Q4 2024 1,701.00 1.21 +0.8% View
Q3 2024 1,578.00 0.97 -5.6% View
Q2 2024 1,573.00 1.05 -8.4% View